Antineoplastic reduces relapse rate, delays disability progression in progressive MS

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 1998年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1170 / 1170
页数：1
相关论文
共 50 条
  • [21] OCRELIZUMAB REDUCES DISABILITY PROGRESSION INDEPENDENT OF RELAPSE ACTIVITY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS (RMS) (ENCORE)
    Kappos, Ludwig
    Wolinsky, Jerry S.
    Giovannoni, Gavin
    Arnold, Douglas L.
    Lublin, Fred
    Wang, Qing
    Model, Fabian
    Wei, Wei
    Garren, Hideki
    Manfrini, Marianna
    Belachew, Shibeshih
    Hauser, Stephen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E25 - E25
  • [22] Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression
    Achiron, Anat
    Dreyer-Alster, Sapir
    Gurevich, Michael
    Menascu, Shay
    Magalashvili, David
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 50
  • [23] Regional brain atrophy rate is related to disability progression in early relapse onset multiple sclerosis
    Jasperse, B.
    Vrenken, H.
    de Groot, V.
    Sanz-Arigita, E.
    Polman, C. H.
    Barkhof, F.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S177 - S177
  • [24] SOCIOECONOMIC STATUS AND PROGRESSION OF DISABILITY IN MS
    Harding, Katharine
    Kingwell, Elaine
    Wardle, Mark
    Zhu, Feng
    Robertson, Neil
    Tremlett, Helen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [25] Natalizumab reduces relapse clinical severity and improves relapse recovery in MS
    Lublin, Fred D.
    Cutter, Gary
    Giovannoni, Gavin
    Pace, Amy
    Campbell, Nolan R.
    Belachew, Shibeshih
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (06) : 705 - 711
  • [26] Cerebellar lobule atrophy and disability in progressive MS
    Cocozza, Sirio
    Petracca, Maria
    Mormina, Enricomaria
    Buyukturkoglu, Korhan
    Podranski, Kornelius
    Heinig, Monika M.
    Pontillo, Giuseppe
    Russo, Camilla
    Tedeschi, Enrico
    Russo, Cinzia Valeria
    Costabile, Teresa
    Lanzillo, Roberta
    Harel, Asaff
    Klineova, Sylvia
    Miller, Aaron
    Brunetti, Arturo
    Morra, Vincenzo Brescia
    Lublin, Fred
    Inglese, Matilde
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (12): : 1065 - 1072
  • [27] Synthetic MRI in Progressive MS: Associations with Disability
    Braga, N.
    Aymerich, F. X.
    Alonso, J.
    Mongay-Ochoa, N.
    Pareto, D.
    Montalban, X.
    Vidal-Jordana, A.
    Sastre-Garriga, J.
    Rovira, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2025, 46 (04) : 847 - 851
  • [28] Comorbidity delays diagnosis and increases disability at diagnosis in MS
    Marrie, R. A.
    Horwitz, R.
    Cutter, G.
    Tyry, T.
    Campagnolo, D.
    Vollmer, T.
    NEUROLOGY, 2009, 72 (02) : 117 - 124
  • [29] Discovery of biomarkers reflecting progression pathophysiology for relapse remitting and primary progressive MS subtypes by multiplex aptamer approach
    Malekzadeh, A.
    Killestein, J.
    Kuhle, J.
    Teunissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 181 - 182
  • [30] Defining beta-interferon failure in multiple sclerosis: impaired relapse rate reduction predicts progressive disability
    O'Rourke, K
    Hutchinson, M
    JOURNAL OF NEUROLOGY, 2005, 252 : 46 - 46
12345